Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Esophageal Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Esophageal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Esophageal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Esophageal Diseases » Esophageal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Esophageal Neoplasms
Hierarchy View
Subtype Terms (1)
Esophageal Squamous Cell Carcinoma
72 drugs (27 approved, 45 experimental)
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (20)
Phase 3 Indicated Drugs (78)
Phase 1 Indicated Drugs (134)
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
anti-ny eso-1 tcr-transduced t cells
autologous dendritic cells loaded with autologous tumor lysate
dec-205/ny-eso-1 fusion protein cdx-1401
her2bi-armed activated t cells
Other Experimental Indicated Drugs (36)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 3 Indications (108)
Australasian Gastro-Intestinal Trials Group
Austrian Society Of Surgical Oncology
Cantonal Hospital of St. Gallen
Centre Georges Francois Leclerc
Chinese University of Hong Kong
Eastern Cooperative Oncology Group
Federation Francophone de Cancerologie Digestive
French Society of Radiation Oncology
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Gruppo Oncologico del Nord-Ovest
Gruppo Oncologico Italiano di Ricerca Clinica
Huai'an First People's Hospital
Huazhong University of Science and Technology
Istituto Nazionale per lo Studio e la Cura dei Tumori
Italian Trial in Medical Oncology
Moorgreen Hospital, Southampton
National Cancer Institute, France
National Health and Medical Research Council, Australia
North Central Cancer Treatment Group
People's Liberation Army of China
Radiation Therapy Oncology Group
Shantou University Medical College
Societe Francaise de Radiotherapie Oncologique
Southern Italy Cooperative Oncology Group
Sunshine Lake Pharma Co., Ltd.
Organization Involved with Phase 2 Indications (222)
Academic and Community Cancer Research United
Anhui Kedgene Biotechnology Co.,Ltd
Arbeitsgemeinschaft medikamentoese Tumortherapie
Betta Pharmaceuticals Co.,Ltd.
Big Ten Cancer Research Consortium
Biotech Pharmaceutical Co., Ltd.
Blokhin's Russian Cancer Research Center
Cancer Biotherapy Research Group
Case Western Reserve University
Centre Hospitalier La Source, Orleans
Changzhou No.2 People's Hospital
Chao Family Comprehensive Cancer Center
City of Hope National Medical Center
Desert Regional Comprehensive Cancer Center
Groupe Hospitalier Paris Saint Joseph
Grupo Espanol Multidisciplinario del Cancer Digestivo
Grupo Gallego de Investigaciones Oncologicas
Guangdong Pharmaceutical University
Guangzhou Anjie Biomedical Technology Co., Ltd.
Helmholtz Centre for Infection Research
Hematology-Oncology Associates of Illinois
Hoag Memorial Hospital Presbyterian
Hoosier Cancer Research Network
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Inner Mongolia Medical University
Innovent Biologics (Suzhou) Co. Ltd.
Institut de Cancerologie de l'Ouest Paul Papin
King Faisal Specialist Hospital
Mashhad University of Medical Sciences
Memorial Cancer Institute, Florida
Memorial Sloan-Kettering Cancer Center
Nang Kuang Pharmaceutical Co., Ltd.
National Comprehensive Cancer Network
Nationales Centrum fur Tumorerkrankungen
North Sichuan Medical University
Oregon Health and Science University
Royal Marsden Hospital NHS Trust
Russian Academy of Medical Sciences
Shanghai Junshi Bioscience Co.,Ltd.
Shenzhen Hank Bioengineering Institute
Shenzhen Hornetcorn Bio-technology Company, LTD
Simcere Pharmaceutical Co., Ltd
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
State University of New York, Buffalo
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Taipei Veteran General hospital
Taizhou Hospital of Zhejiang Province
Technical University of Munich
The East Hospital of Lianyungang
The University of Texas, Dallas
Translational Oncology Research International
Universidad Autonoma de Barcelona
Universitaetsklinikum Schleswig-Holstein
University of Alabama, Birmingham
University of California, Irvine
University of California, San Diego
University of California, San Francisco
University of Nice Sophia Antipolis
University of North Carolina at Chapel Hill
University of Southern California
University of Texas at Houston
University of Texas, Galveston
University of Texas, San Antonio
Organization Involved with Phase 1 Indications (44)
Guangdong Xiangxue Precision Medical Technology Co., Ltd
Guangzhou Xiangxue Pharmaceutical Co., Ltd
Japanese Foundation for Cancer Research
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
